News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Luye Pharma Group Ltd. To Conduct $750 Million Hong Kong IPO


2/10/2014 11:57:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

February 10, 2014 -- Luye Pharma is planning to stage a $750 million IPO in Hong Kong. Luye is a China company that makes TCM products, innovative drugs and biotech products. It is controlled by three China private equity companies, which bought a 77% stake in Luye in 2012 when the company had a market capitalization of $320 million. Later that year, the PE firms bought out the public shareholders and delisted Luye from the Singapore exchange. The new Hong Kong IPO is expected to value Luye at somewhere in the $1-$1.5 billion range. More details....

Help employers find you! Check out all the jobs and post your resume

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES